文献速递免疫规划职业卫生传染病防控与疫情报告

CoronaVac在真实世界中的保护效果随时间减弱:医护人员回顾性队列研究

Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
PubMed 文献 · Vaccine · 2022-03-19

在土耳其伊斯坦布尔一家大学医院的4067名医护人员中开展回顾性队列研究,评估两剂CoronaVac疫苗在Alpha变异株流行期间对COVID-19感染的保护效果。未接种组与完全接种组的SARS-CoV-2感染发病率分别为每10万人日133.7例和70.7例,调整后疫苗有效性为39%(95%CI 20-64%),低于临床试验结果。

要点

  • 完全接种两剂CoronaVac的医护人员占71%,未接种任何剂次者占29%。
  • 未接种组SARS-CoV-2感染发病率为每10万人日133.7例,完全接种组为70.7例。
  • 调整后疫苗有效性为39%(95%CI 20-64%),作者认为可能需加强针。

核心结论

  • 在医护人员中开展的真实世界研究显示,两剂CoronaVac疫苗的有效性(39%)低于临床试验中确定的有效性。
  • 由于保护随时间减弱或针对变异株,可能需要加强针。

研究设计与样本

  • 回顾性队列研究,在土耳其伊斯坦布尔一家大学医院开展,纳入4067名医护人员。
  • 随访期从完全接种组接种第二剂后14天开始;医护人员PCR检测阳性或研究结束时删失;未接种者若接种任何COVID-19疫苗剂次则删失。
  • 使用发病率比值和Cox回归估计未调整和调整后的疫苗有效性。

主要发现

  • 71%的医护人员完全接种,29%未接种任何剂次。
  • 未接种组SARS-CoV-2感染发病率为每10万人日133.7例,完全接种组为每10万人日70.7例。
  • 未调整的针对COVID-19感染的有效性为47%(95%CI 31-59%),调整后有效性为39%(95%CI 20-64%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Real-world studies showed varying levels of effectiveness of CoronaVac vaccine against COVID-19 disease. This study aimed to assess the association between the vaccination with CoronaVac and the COVID-19 infections among the health care workers in a university hospital and to determine the vaccine effectiveness against COVID-19 in a period when alpha variant was dominant. METHODS: This retrospective cohort study was conducted in a university hospital in Istanbul, Turkey employs 4067 health care workers. The follow-up period was defined as starting 14 days after receiving the second dose for fully vaccinated group. Health care workers were censored when have a positive PCR test result or at the end of the study. Unvaccinated health care workers were censored if they receive any COVID-19 vaccine doses. The incidence rate ratio and Cox regression were used to estimate the unadjusted and adjusted effectiveness of the vaccine. FINDINGS: Seventy-one percent of the health care workers were fully vaccinated whereas 29% percent did not receive any doses. The incidence rate of SARS-CoV-2 infection was 133.7 vs 70.7 per 100.000 person-days in the unvaccinated and fully vaccinated groups, respectively. The unadjusted effectiveness against COVID-19 infection was 47% (95% CI 31-59%) whereas adjusted effectiveness was 39% (95% CI 20-64%). INTERPRETATION: This real life study conducted in health care workers demonstrated that the effectiveness of two doses of the CoronaVac vaccine (39%) was lower than that determined in clinical trials. Due to reduce in protection over time or against variants, booster doses may be needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Can G, Acar HC, Aydin SN, et al. Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers. Vaccine. 2022. PMID: 35317942. doi:10.1016/j.vaccine.2022.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。